The Inflation Reduction Act: An Opportunity to Accelerate Confidence in US Real-World Evidence.
The objective of this commentary is to explore the implications of the IRA for US pharmaceutical companies, with a specific focus on the role of real-world evidence (RWE) in the context of Medicare reforms.
Source: Value in Health - Category: International Medicine & Public Health Authors: Paul Arora, Alind Gupta, Emma Mackay, Bart Heeg, Kristian Thorlund Source Type: research
More News: International Medicine & Public Health | Medicare